BDTX
Price
$2.58
Change
+$0.09 (+3.61%)
Updated
Jun 6 closing price
Capitalization
146.71M
66 days until earnings call
HUMA
Price
$2.59
Change
-$0.03 (-1.15%)
Updated
Jun 6 closing price
Capitalization
401.76M
73 days until earnings call
Interact to see
Advertisement

BDTX vs HUMA

Header iconBDTX vs HUMA Comparison
Open Charts BDTX vs HUMABanner chart's image
Black Diamond Therapeutics
Price$2.58
Change+$0.09 (+3.61%)
Volume$1.66M
Capitalization146.71M
Humacyte
Price$2.59
Change-$0.03 (-1.15%)
Volume$6.64M
Capitalization401.76M
BDTX vs HUMA Comparison Chart
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. HUMA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and HUMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BDTX: $2.58 vs. HUMA: $2.59)
Brand notoriety: BDTX and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 143% vs. HUMA: 150%
Market capitalization -- BDTX: $146.71M vs. HUMA: $401.76M
BDTX [@Biotechnology] is valued at $146.71M. HUMA’s [@Biotechnology] market capitalization is $401.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 5 TA indicator(s) are bullish while HUMA’s TA Score has 5 bullish TA indicator(s).

  • BDTX’s TA Score: 5 bullish, 3 bearish.
  • HUMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than HUMA.

Price Growth

BDTX (@Biotechnology) experienced а +17.27% price change this week, while HUMA (@Biotechnology) price change was -3.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

HUMA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($402M) has a higher market cap than BDTX($147M). BDTX YTD gains are higher at: 20.561 vs. HUMA (-48.713). BDTX has higher annual earnings (EBITDA): -78.44M vs. HUMA (-137.16M). BDTX has more cash in the bank: 98.6M vs. HUMA (20.6M). HUMA has less debt than BDTX: HUMA (17.3M) vs BDTX (22.2M). BDTX (0) and HUMA (0) have equivalent revenues.
BDTXHUMABDTX / HUMA
Capitalization147M402M37%
EBITDA-78.44M-137.16M57%
Gain YTD20.561-48.713-42%
P/E Ratio43.00N/A-
Revenue00-
Total Cash98.6M20.6M479%
Total Debt22.2M17.3M128%
TECHNICAL ANALYSIS
Technical Analysis
BDTXHUMA
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFESX16.090.07
+0.44%
DFA Emerging Markets Social Core Port
PMGJX7.71N/A
N/A
Principal MidCap Growth J
FATEX106.58N/A
N/A
Fidelity Advisor Technology M
SRICX11.42N/A
N/A
Gabelli SRI C
AREEX26.27N/A
N/A
American Century Real Estate A

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with AURA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-1.15%
AURA - HUMA
36%
Loosely correlated
+6.56%
PRLD - HUMA
36%
Loosely correlated
+5.30%
RXRX - HUMA
36%
Loosely correlated
+20.13%
ACRV - HUMA
34%
Loosely correlated
+8.00%
BDTX - HUMA
34%
Loosely correlated
+3.61%
More